Sagility India Limited - IPO
MAINBOARDSagility India Stock Price
Sagility India IPO Details
Sagility India IPO Subscription
Sagility India IPO Application Wise Breakup (Approx)
Sagility India IPO Dates
- 05 Nov 2024Opening dateOPD
- 07 Nov 2024Closing dateCOD
- 08 Nov 2024Basis of AllotmentBOA
- 11 Nov 2024Initiation of RefundsIOR
- 11 Nov 2024Credit of SharesCOS
- 12 Nov 2024Listing dateLID
Sagility India IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retain Minimum | 1 | 500 | ₹15,000 |
| Retain Maximum | 13 | 6500 | ₹195,000 |
| SHNI Minimum | 14 | 7000 | ₹210,000 |
| SHNI Maximum | 66 | 33000 | ₹990,000 |
| BHNI Minimum | 67 | 33500 | ₹1,005,000 |
Sagility India IPO Reservation
Promoter Holding
Sagility India IPO Valuations
Sagility India Limited Financial Information
Sagility India Limited's revenue increased by 13% and profit after tax (PAT) rose by 59% between the financial year ending with March 31, 2024 and March 31, 2023.
| Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 10,388.01 | 10,664.2 | 10,590.48 | 10,096.28 | ||||||||||||||||||||||||||||||||||||
| Revenue | 1,247.76 | 4,781.5 | 4,236.06 | 944.39 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 22.29 | 228.27 | 143.57 | -4.67 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 7,608.16 | 6,443.13 | 6,206.67 | 4,026.62 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 2,704.28 | 1,855.44 | 4,013.38 | 2,073.8 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 943.91 | 1,933.52 | 2,347.94 | 4,239.23 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
About Sagility India IPO
Sagility India Limited, formerly known as Berkmeer India Private Limited, provides healthcare-focused solutions and services to Payers (US health insurers who fund and reimburse the cost of healthcare services) and Providers (primarily hospitals, physicians, diagnostics and medical technology companies).
The company supports the core business of both payers and providers. Services to payers span their entire operational spectrum, including centralized claims administration and clinical services functions. These include claims administration, payment integrity, clinical management and other services. For providers, the company offers revenue cycle management services to assist them in managing their billing and claiming treatment costs from payers. In addition, the Company also offers some of the services it provides to Payers to Pharmacy Benefit Managers (“PBMs”) who manage prescription drug coverage for members (i.e., insureds) under health benefit plans.
The company's customers are all based in the USA. As of March 31, 2024, the Company's five largest customer groups (i.e. the customer companies together with their subsidiaries) had an average tenure of service of 17 years. In January 2024, the company served five of the ten largest payers in the US (source: Everest Report). In addition, the company acquired 20 new customers in the financial years 2024 and 2023.
As of March 31, 2024, Sagility India had 35,044 employees, of which 60.52% were women. As of March 31, 2024, 1,687 of the employees held certifications, including 374 certified medical coders, 1,280 registered nurses in the US, Philippines and India, and 33 employees with other degrees such as dentistry, surgery and pharmacy.
Strength Of Sagility India IPO
1. Leadership position in the large and resilient U.S. Payer and Provider solutions market.
2. Domain expertise in healthcare operations, with end-to-end service offerings to Payers and Providers.
3. Suite of scalable, technology-enabled services and solutions, supported by proprietary tools and platforms.
4. Deep, long-term, expanding client relationships across healthcare Payers and Providers.
5. Multi-shore, scalable and flexible delivery model with certified data protection and service standards.
6. Experienced management and board, motivated employee base, marquee sponsor support and a sustainability focused culture.
Risk Of Sagility India IPO
1. The healthcare services industry is highly competitive and if we are unable to compete effectively, it may adversely affect our business, financial condition and results of operations.
2. Our business is solely focused on the U.S. healthcare industry and may be adversely affected by factors affecting the U.S. healthcare industry, including a decline in the growth of the U.S. healthcare industry, reduction in outsourcing and other trends.
3. Our business could be adversely affected if we cannot keep pace with technological changes, sufficiently invest and successfully yield the intended results from our investments in technology, in case of any errors or system disruptions in our technology tools and platforms, or if our services are rendered obsolete by technological developments.
4. If we are unable to manage our employee expenses and resource utilization or fail to manage attrition and attract and retain skilled professionals, it may adversely affect our business, financial condition and results of operations.
5. If we fail to deliver services in accordance with contractual requirements, we could be subject to significant costs or liability and our business, reputation and results of operations could be adversely affected.
6. If our agreements with clients are terminated, our business, reputation and results of operations could be adversely affected.
7. As a significant portion of our business is attributable to certain large client groups in the U.S., our business and profitability is dependent on our continuing relationships with such key clients.
8. There are outstanding legal proceedings involving our Company, Subsidiaries and Directors. Any adverse decision in such proceedings may adversely affect our business, financial condition, and results of operations.
9. If we are not able to generate new service engagements, or if our business volumes fluctuate, it may adversely affect our ability to grow our business and revenues.
10. If we fail to accurately price our statements of work or overrun our cost estimates, our business, financial condition and results of operations may be adversely affected.
Objectives Sagility India IPO
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges, and
- Carry out the Offer for Sale of up to 702,199,262 Equity Shares of the face value of Rs. 10 each by the Promoter Selling Shareholder.
Company Contact Details
Sagility India Limited
No. 23 & 24, AMR Tech Park,
Building 2A, First Floor, Hongasandara Village,
Off Hosur Road, Bommanahalli, Bengaluru - 560 068
Phone: +91- 80-7125 150
Email: investorservice@sagilityhealth.com
Website: http://www.sagilityhealth.com/
Registrar Contact Details
Lead Mangers
Iifl Securities Ltd
ICICI Securities Limited
Jefferies India Private Limited
J.P. Morgan India Private Limited